Evidence map›Paper›PMID 36072603›Full record

ArticleFrontiers in immunology2022

Characterization of an intelectin-1 (

Eric B Nonnecke, Patricia A Castillo, Douglas T Akahoshi, Stephanie M Goley, Charles L Bevins, Bo Lönnerdal

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Soluble Human Lectins at the Host-Microbe Interface.Annual review of biochemistry · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Eric B NonneckeDepartment of Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, CA, United States.
Patricia A CastilloDepartment of Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, CA, United States.
Douglas T AkahoshiDepartment of Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, CA, United States.
Stephanie M GoleyDepartment of Nutrition, University of California, Davis, Davis, CA, United States.
Charles L BevinsDepartment of Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, CA, United States.
Bo LönnerdalDepartment of Nutrition, University of California, Davis, Davis, CA, United States.
University of California, Davis · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Barbara L. Shacklett · 2002 to 2026
$84.9M
High-throughput targeted mutagenesis of mouse stem cell linesU01HG004080 · NHGRI · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI DE JONG, PIETER J. · 2006 to 2010
$28.1M
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES CellsU01HG004085 · NHGRI · REGENERON PHARMACEUTICALS, INC. · PI VALENZUELA, DAVID MANUEL · 2006 to 2010
$25.3M
UCD KOMP PROJECT REPOSITORYU42RR024244 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LLOYD, KC KENT · 2007 to 2010
$7.9M
Animal Models of Infectious Diseases Training ProgramT32AI060555 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI MCSORLEY, STEPHEN J · 2004 to 2025
$3.3M
Novel Defensins in Human Epithelial TissuesR37AI032738 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BEVINS, CHARLES L · 2015 to 2022
$3.1M
Paneth Cell Secreted Effectors in Mucosal Innate ImmunityU01AI125956 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BEVINS, CHARLES L · 2016 to 2020
$2.3M
NCI NIH HHS P30 CA093373NCRR NIH HHS U42 RR024244NHGRI NIH HHS U01 HG004080NHGRI NIH HHS U01 HG004085NIAID NIH HHS R37 AI032738NIAID NIH HHS T32 AI060555NIAID NIH HHS U01 AI125956
6 · The paper itself

Abstract

Intelectins are carbohydrate-binding proteins implicated in innate immunity and highly conserved across chordate evolution, including both ascidians and humans. Human intelectin-1 (ITLN1) is highly abundant within the intestinal mucosa and binds microbial but not host glycans. Genome-wide association studies identified SNPs in

Indexed as

ColitisCytokinesGenome-Wide Association StudyGPI-Linked ProteinsLectinsAnimalsDisease Models, AnimalHumansMiceMice, Inbred C57BLMice, KnockoutObesityCytokinesGPI-Linked ProteinsItln1 protein, mouseLectinsadipokineIBDinnate immunitylectinLieberkühnmucosal immunityomentintm1a

Identifiers

PMID36072603
PMCPMC9441953
OpenAlexW4292590113

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.